Patent Assignment
Reel/Frame 028275/0729
Assignment of Assignor's Interest
Recorded: 2012-05-25
Pages: 3
Assignor
BULUSU, ATCHYUTA RAMA CHANDRA MURTY
Executed: 2012-05-09
Assignee
NABRIVA THERAPEUTICS AG
LEBERSTRASSE 20, WIEN, A-1112, AUSTRIA
Covered Property
(1)
Substituted Clavulanic Acid
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Lien
Sep 5, 2014
From: NABRIVA THERAPEUTICS AG
To: KREOS CAPITAL IV (UK) LIMITED
Reel/Frame 033694/0165 →
Release of Security Interest
Nov 24, 2015
From: KREOS CAPITAL IV (UK) LIMITED
To: NABRIVA THERAPEUTICS AG
Reel/Frame 037134/0479 →
Intellectual Property Security Agreement
Dec 20, 2018
From: NABRIVA THERAPEUTICS GMBH
To: HERCULES CAPITAL, INC.
Reel/Frame 047973/0110 →
Release of Security Interest
Mar 3, 2023
From: HERCULES CAPITAL, INC.
To: NABRIVA THERAPEUTICS GMBH; ZAVANTE THERAPEUTICS, INC.
Reel/Frame 062881/0090 →
Corrective Assignment to Correct the Receiving Party Data and the Assignment Document Previously Recorded at Reel: 062881 Frame: 0090. Assignor(S) Hereby Confirms the Release of Security Interest.
Jun 20, 2023
From: HERCULES CAPITAL, INC.
To: NABRIVA THERAPEUTICS GMBH
Reel/Frame 064312/0350 →